Latest Shareholder Value News

NuEnergy Gas Limited has completed drilling four wells at its Tanjung Enim project, gearing up for initial gas sales in the first half of FY26. The company also inked key agreements to finance and expand its coal bed methane operations in Indonesia.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Kula Gold Limited shares have been suspended following Forrestania Resources’ compulsory acquisition, with delisting scheduled for early February 2026.

Aeris Resources delivered steady copper and gold output in Q2 FY26, achieving a debt-free balance sheet and a robust cash position. Exploration drilling at Tritton signals promising resource extensions.

Premier1 Lithium Limited has completed the full acquisition of the Yalgoo Gold Project in Western Australia, consolidating its position in a highly prospective gold belt and preparing for an aggressive exploration campaign in 2026.

Aeris Resources delivered solid Q2 FY26 results with copper equivalent production of 10.1kt at competitive costs, strengthened its balance sheet by repaying debt, and reported promising exploration outcomes that could underpin future growth.

Brazilian Rare Earths Limited (BRE) reports a robust scoping study for its Amargosa Bauxite-Gallium Project, alongside a strategic heavy rare earths partnership and a strong cash position to accelerate development.

Flynn Gold Limited has reported promising high-grade gold results from its Golden Ridge Project in Tasmania, alongside a successful $5 million capital raise to accelerate exploration efforts in 2026.

Odyssey Gold Limited has successfully raised approximately $9 million through a placement to fund accelerated development at its Tuckanarra Gold Project in Western Australia.

Image Resources NL reported a strong finish to 2025 with record heavy mineral concentrate production and sales, alongside promising developments in its gold exploration and synthetic rutile innovation.

Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.